A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.
This study has been completed.
Sponsor:
Janssen, LP
Information provided by:
Janssen, LP
ClinicalTrials.gov Identifier:
NCT00495118
First received: June 29, 2007
Last updated: May 16, 2011
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2005 |
| Estimated Primary Completion Date: | No date given |